1. Currently, pharmaceutical CBD is mainly produced in Europe, with a small amount produced in China. The main purchaser is GW Pharm, which I mentioned, for several rare diseases (already fD-approved) including ASL (multiple sclerosis), LGS (early-onset epilepsy in children), AND NHIE (hypoxic ischemic encephalopathy in newborns). Prescription drugs, not available. Unless you have the connections to buy the API directly.
2. Food-grade CBD, extracted from medicinal cannabis, is more reliable but regulated. The United States cannot sell across state lines. Chinese law is not clear, so it cannot be imported.
3, food grade CBD, extracted from hemp (industrial hemp), can be legally sold. But because hemp CBD content itself is low, most quality is doubtful. The FDA tested six varieties of hemp CBD on the market in March this year, all claiming to contain more than 20%. In fact, the highest level was only 0.5%, and the lowest level was none.
Finally: THE psychosis and brain protection effects of CBD have been basically confirmed, but the treatment of schizophrenia is still under study. Preliminary thought it might work, but not proven. Try it at your own risk. If the demand is really great, we can invest in it, manufacture it in small quantities and sell it on a non-profit basis.

